175 related articles for article (PubMed ID: 8646851)
1. Type III cyclic nucleotide phosphodiesterases and insulin action.
Manganiello VC; Degerman E; Taira M; Kono T; Belfrage P
Curr Top Cell Regul; 1996; 34():63-100. PubMed ID: 8646851
[No Abstract] [Full Text] [Related]
2. Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1).
Kakkar R; Raju RV; Sharma RK
Cell Mol Life Sci; 1999 Jul; 55(8-9):1164-86. PubMed ID: 10442095
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotides and phosphodiesterases in platelets.
Haslam RJ; Dickinson NT; Jang EK
Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
[No Abstract] [Full Text] [Related]
4. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
Rybalkin SD; Bornfeldt KE
Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
[No Abstract] [Full Text] [Related]
5. Recent advances in the study of Ca2+/CaM-activated phosphodiesterases: expression and physiological functions.
Zhao AZ; Yan C; Sonnenburg WK; Beavo JA
Adv Second Messenger Phosphoprotein Res; 1997; 31():237-51. PubMed ID: 9344255
[No Abstract] [Full Text] [Related]
6. Cyclic nucleotide phosphodiesterases: gene complexity, regulation by phosphorylation, and physiological implications.
Burns F; Zhao AZ; Beavo JA
Adv Pharmacol; 1996; 36():29-48. PubMed ID: 8783553
[No Abstract] [Full Text] [Related]
7. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.
Stehlik J; Movsesian MA
Expert Opin Investig Drugs; 2006 Jul; 15(7):733-42. PubMed ID: 16787138
[TBL] [Abstract][Full Text] [Related]
8. Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells.
Diederen RM; La Heij EC; Markerink-van Ittersum M; Kijlstra A; Hendrikse F; de Vente J
Br J Ophthalmol; 2007 Mar; 91(3):379-84. PubMed ID: 16943225
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms involved in the antilipolytic action of insulin: phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase.
Manganiello VC; Smith CJ; Degerman E; Vasta V; Tornqvist H; Belfrage P
Adv Exp Med Biol; 1991; 293():239-48. PubMed ID: 1662861
[No Abstract] [Full Text] [Related]
10. The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrations.
Houslay MD
Cell Signal; 1990; 2(1):85-98. PubMed ID: 2176803
[TBL] [Abstract][Full Text] [Related]
11. Multiplicity within cyclic nucleotide phosphodiesterases.
Rybalkin SD; Beavo JA
Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
[No Abstract] [Full Text] [Related]
12. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterases and regulation of female reproductive function.
Conti M
Curr Opin Pharmacol; 2011 Dec; 11(6):665-9. PubMed ID: 22019564
[TBL] [Abstract][Full Text] [Related]
14. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.
Qiu Y; Kraft P; Lombardi E; Clancy J
J Urol; 2000 Sep; 164(3 Pt 1):882-6. PubMed ID: 10953172
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.
Hickie RA
Adv Exp Med Biol; 1977 May 22-24; 92():451-88. PubMed ID: 24988
[No Abstract] [Full Text] [Related]
17. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.
Soderling SH; Bayuga SJ; Beavo JA
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7071-6. PubMed ID: 10359840
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
Wells JN; Kramer GL
Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
[No Abstract] [Full Text] [Related]
19. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
20. Molecular events in the action of insulin on cell metabolism. The significance of cyclic AMP dependent protein kinases.
Walaas O; Walaas E; Gronnerod O
Acta Endocrinol Suppl (Copenh); 1974; 191():93-129. PubMed ID: 4375385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
